Docstoc

Arteriosclerosis Global Clinical Trials Review

Document Sample
Arteriosclerosis Global Clinical Trials Review Powered By Docstoc
					Arteriosclerosis Global Clinical Trials Review, Q4, 2010
Arteriosclerosis Global Clinical Trials Review, Q4, 2010
GlobalData

Date: Nov, 2010
Pages: 67
Price: US$ 1,000.00
ID: AA9D6D57216EN

Arteriosclerosis Global Clinical Trials Review, Q4, 2010

Summary

GlobalData's clinical trial report, "Arteriosclerosis Global Global Clinical Trials Review, Q4, 2010" provides
data on the Arteriosclerosis clinical trial scenario. This report provides in-depth information and data relating
to the clinical trials on Arteriosclerosis. It includes an overview of the trial numbers and their recruitment
status as per the site of trial development throughout the world, focusing on the status of participation by the
developing nations. It offers coverage of disease clinical trials by their phase, trial status, prominence of the
sponsors and also provides information pertaining to the number of trials for the key drugs for treating
Arteriosclerosis.

This report is built using data and information sourced from proprietary databases, primary and secondary
research and in-house analysis by GlobalData's team of industry experts.

Scope

         • Data on the number of clinical trials conducted in North America, South And Central America,
           Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along
           with the clinical trial scenario in BRIC nations
         • Clinical trial (complete and in progress) data by phase, trial status and trial success rate
         • Review of key discontinued trials (suspended, withdrawn and terminated)
         • Overview of the enrollment pattern by phase for the past decade
         • Number of clinical trials segmented by key drugs
         • Clinical trial overview of top 20 companies, which include Pfizer Inc., AstraZeneca PLC, Eli Lilly
           and Company, and so on.
         • Clinical trial overview of top 20 Universities / Institutes / Hospitals including National Cancer
           Institute, Cancer Research UK, Cancer Research Institute , and others


Reasons to buy

         • Understand the dynamics of a particular indication as a whole
         • Examine the performance of the trials in terms of their status, recruitment, success rates and others
         • Obtain discontinued trial information for trials across the globe
         • Understand the commercial landscape of the major Universities / Institutes / Hospitals or Companies




Arteriosclerosis Global Clinical Trials Review, Q4, 2010                                                            1
Arteriosclerosis Global Clinical Trials Review, Q4, 2010 - Table of Content

1 TABLE OF CONTENTS

1.1 List of Tables
1.2 List of Figures

2 INTRODUCTION

2.1 Arteriosclerosis
2.2 Report Guidance

3 CLINICAL TRIALS BY REGION

3.1 Clinical Trials by Country
 3.1.1 Top Five Countries Contributing to Clinical Trials in Asia-Pacific
 3.1.2 Top Five Countries Contributing to Clinical Trials in Europe
 3.1.3 Top Countries Contributing to Clinical Trials in North America
 3.1.4 Top Countries Contributing to Clinical Trials in Middle East and Africa
 3.1.5 Top Countries Contributing to Clinical Trials in Central and South America
3.2 Clinical Trials by BRIC Countries

4 CLINICAL TRIALS BY PHASE

4.1 In Progress Trials by Phase

5 CLINICAL TRIALS BY TRIAL STATUS

6 UNACCOMPLISHED TRIALS OF ARTERIOSCLEROSIS

7 SUBJECTS RECRUITED OVER A PERIOD OF TIME

8 PROMINENT SPONSORS

8.1 Top Companies Participating in Arteriosclerosis Therapeutics Clinical Trials

9 PROMINENT DRUG COMPARISON

10 CLINICAL TRIAL PROFILES

10.1 Clinical Trial Overview of Top Companies
 10.1.1 Merck & Co., Inc.
 10.1.2 GlaxoSmithKline plc
 10.1.3 Abbott Laboratories
 10.1.4 AstraZeneca PLC
 10.1.5 Bristol-Myers Squibb Company
 10.1.6 Daiichi Sankyo Company, Ltd
 10.1.7 Johnson & Johnson
 10.1.8 Lutonix, Inc.
 10.1.9 Pfizer Inc.

Arteriosclerosis Global Clinical Trials Review, Q4, 2010 - Table of Content         2
 10.1.10 F. Hoffmann-La Roche Ltd.
 10.1.11 The Medicines Company
 10.1.12 Boston Scientific Corporation
 10.1.13 Sanofi-Aventis
 10.1.14 VPDiagnostics, Inc.
 10.1.15 DePuy, Inc.
 10.1.16 Viron Therapeutics, Inc.
 10.1.17 VIA Pharmaceuticals, Inc.
 10.1.18 TCA Cellular Therapy
 10.1.19 Schering-Plough Corporation (Inactive)
 10.1.20 Azienda Unità Sanitaria Locale di Piacenza
10.2 Clinical Trial Overview of Top Universities / Institutes / Hospitals
 10.2.1 National Heart, Lung, and Blood Institute
 10.2.2 Brigham and Women's Hospital
 10.2.3 National Institute on Aging
 10.2.4 Korea University
 10.2.5 Johns Hopkins University
 10.2.6 National Taiwan University Hospital
 10.2.7 Brigham and Women's Hospital
 10.2.8 UMC Utrecht
 10.2.9 Copenhagen University Hospital at Herlev
 10.2.10 University of Wisconsin Madiso
 10.2.11 University of Sao Paulo
 10.2.12 The National Institute of Allergy and Infectious Diseases
 10.2.13 Mayo Clinic
 10.2.14 Kurume University
 10.2.15 The National Institute of Diabetes and Digestive and Kidney Diseases
 10.2.16 Assaf-Harofeh Medical Center
 10.2.17 Hadassah Medical Organization
 10.2.18 HaEmek Medical Center, Israel
 10.2.19 Maastricht University Medical Center
 10.2.20 University of Zurich

11 APPENDIX

11.1 Abbreviations
11.2 Definitions
11.3 Research Methodology
11.4 Secondary Research
11.5 About GlobalData
11.6 Contact Us
11.7 Disclaimer
11.8 Source 66

LIST OF TABLES

Table 1: Arteriosclerosis Therapeutics Market, Global, Clinical Trials by Zone, 2010*
Table 2: Arteriosclerosis Therapeutics Clinical Trials and in Progress Trials Market, Global, by Top
Countries, 2010*
Table 3: Arteriosclerosis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2010*

Arteriosclerosis Global Clinical Trials Review, Q4, 2010 - Table of Content                            3
Table 4: Arteriosclerosis Therapeutics Clinical Trials, Europe, Top Five Countries, 2010*
Table 5: Arteriosclerosis Therapeutics Clinical Trials, North America, Top Countries, 2010*
Table 6: Arteriosclerosis Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2010*
Table 7: Arteriosclerosis Therapeutics Clinical Trials, Central and South America, Top Countries, 2010*
Table 8: Arteriosclerosis Therapeutics Clinical Trials, BRIC Countries, 2010*
Table 9: Arteriosclerosis Therapeutics Market, Global, Clinical Trials by Phase, 2010*
Table 10: Arteriosclerosis Therapeutics Market, Global, Clinical Trials in Progress by Phase 2010*
Table 11: Arteriosclerosis Therapeutics Market, Global, Clinical Trials by Trial Status, 2010*
Table 12: Arteriosclerosis Therapeutics Market, Global, Suspended Clinical Trials, 2010*
Table 13: Arteriosclerosis Therapeutics Market, Global, Withdrawn Clinical Trials, 2010*
Table 14: Arteriosclerosis Therapeutics Market, Global, Terminated Clinical Trials, 2010*
Table 15: Arteriosclerosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends,
2005-2009
Table 16: Arteriosclerosis Therapeutics Clinical Trials, Global, Key Sponsors, 2010*
Table 17: Arteriosclerosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2010*
Table 18: Arteriosclerosis Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2010*
Table 19: Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc.,
2010*
Table 20: Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline
plc., 2010*
Table 21: Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Abbott Laboratories,
2010*
Table 22: Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC,
2010*
Table 23: Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers
Squibb Company, 2010*
Table 24: Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Daiichi Sankyo
Company, Ltd, 2010*
Table 25: Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson,
2010*
Table 26: Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Lutonix, Inc.,
2010*
Table 27: Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2010*
Table 28: Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La
Roche Ltd., 2010*
Table 29: Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by The Medicines
Company, 2010*
Table 30: Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Boston Scientific
Corporation, 2010*
Table 31: Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi-Aventis,
2010*
Table 32: Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by VPDiagnostics, Inc.,
2010*
Table 33: Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by DePuy, Inc., 2010*
Table 34: Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Viron Therapeutics,
Inc., 2010*
Table 35: Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by VIA
Pharmaceuticals, Inc., 2010*
Table 36: Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by TCA Cellular
Therapy, 2010*

Arteriosclerosis Global Clinical Trials Review, Q4, 2010 - Table of Content                                   4
Table 37: Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Schering-Plough
Corporation (Inactive), 2010*
Table 38: Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Azienda Unità
Sanitaria Locale di Piacenza, 2010*
Table 39: Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by National Heart,
Lung, and Blood Institute, 2010*
Table 40: Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Brigham and
Women's Hospital, 2010*
Table 41: Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute on
Aging, 2010*
Table 42: Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Korea University,
2010*
Table 43: Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Johns Hopkins
University, 2010*
Table 44: Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by National Taiwan
University Hospital, 2010*
Table 45: Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Brigham and
Women's Hospital, 2010*
Table 46: Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by UMC Utrecht,
2010*
Table 47: Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Copenhagen
University Hospital at Herlev, 2010*
Table 48: Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of
Wisconsin Madison, 2010*
Table 49: Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Sao
Paulo, 2010*
Table 50: Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by The National
Institute of Allergy and Infectious Diseases, 2010*
Table 51: Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic,
2010*
Table 52: Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Kurume University,
2010*
Table 53: Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by The National
Institute of Diabetes and Digestive and Kidney Diseases, 2010*
Table 54: Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Assaf-Harofeh
Medical Center, 2010*
Table 55: Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Hadassah Medical
Organization, 2010*
Table 56: Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by HaEmek Medical
Center, Israel, 2010*
Table 57: Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Maastricht
University Medical Center, 2010*
Table 58: Arteriosclerosis Therapeutics Clinical Trials Market, Global, Clinical Trials by University Zurich,
2010* 62

LIST OF FIGURES

Figure 1: Arteriosclerosis Therapeutics Market, Global, Clinical Trials by Zone (%), 2010*
Figure 2: Arteriosclerosis Therapeutics Market, Global, Clinical Trials by Top Countries, 2010*
Figure 3: Arteriosclerosis Therapeutics Market, Global, Clinical Trials in Progress by Top Countries, 2010*

Arteriosclerosis Global Clinical Trials Review, Q4, 2010 - Table of Content                                    5
Figure 4: Arteriosclerosis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2010*
Figure 5: Arteriosclerosis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2010*
Figure 6: Arteriosclerosis Therapeutics Clinical Trials, North America, Top Countries (%), 2010*
Figure 7: Arteriosclerosis Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2010*
Figure 8: Arteriosclerosis Therapeutics Clinical Trials, Central and South America, Top Countries (%),
2010*
Figure 9: Arteriosclerosis Therapeutics Clinical Trials, BRIC Countries (%), 2010*
Figure 10: Arteriosclerosis Therapeutics Market, Global, Clinical Trials by Phase (%), 2010*
Figure 11: Arteriosclerosis Therapeutics Market, Global, Clinical Trials in Progress by Phase, 2010*
Figure 12: Arteriosclerosis Therapeutics Market, Global, Clinical Trials by Trial Status, 2010*
Figure 13: Arteriosclerosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends,
2005-2009
Figure 14: Arteriosclerosis Therapeutics Clinical Trials, Global, Key Sponsors, 2010*
Figure 15: Arteriosclerosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2010*
Figure 16: Arteriosclerosis Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2010*
Figure 17: GlobalData Methodology 65




Arteriosclerosis Global Clinical Trials Review, Q4, 2010 - Table of Content                                   6
I would like to order:

Product name: Arteriosclerosis Global Clinical Trials Review, Q4, 2010
Product link: http://marketpublishers.com/r/AA9D6D57216EN.html
Product ID: AA9D6D57216EN
Price: US$ 1,000.00 (Single User License / Electronic Delivery)

If you want to order Corporate License or Hard Copy, please, contact our Customer Service:
office@marketpublishers.com

Payment

To pay by Credit Card (Visa, MasterCard, American Express, PayPal), please, click 'BUY NOW' button on
product page http://marketpublishers.com/r/AA9D6D57216EN.html

				
DOCUMENT INFO